Unveiling potent Schiff base derivatives with selective xanthine oxidase inhibition:
Gout
In silico approach
Schiff base
Triazole
Xanthine oxidase inhibition
Journal
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
ISSN: 1319-0164
Titre abrégé: Saudi Pharm J
Pays: Saudi Arabia
ID NLM: 9705695
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
received:
24
02
2024
accepted:
02
04
2024
medline:
11
4
2024
pubmed:
11
4
2024
entrez:
11
4
2024
Statut:
ppublish
Résumé
This research describes the synthesis by an environmentally-friendly method, microwave irradiation, development and analysis of three novel and one previously identified Schiff base derivative as a potential inhibitor of bovine xanthine oxidase (BXO), a key enzyme implicated in the progression of gout. Meticulous experimentation revealed that these compounds (
Identifiants
pubmed: 38601975
doi: 10.1016/j.jsps.2024.102062
pii: S1319-0164(24)00112-9
pmc: PMC11004395
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102062Informations de copyright
© 2024 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.